Nelvagal, Hemanth R.
Hurtado, Maica Llavero
Eaton, Samantha L.
Kline, Rachel A.
Lamont, Douglas J.
Sands, Mark S.
Wishart, Thomas M.
Cooper, Jonathan D.
Funding for this research was provided by:
King's College London (International Graduate School PhD studentship)
Biotechnology and Biological Sciences Research Council (Institute Strategic Programme (ISPG/5 12-17), Institute Strategic Programme (ISPG/1 18-22))
Euan MacDonald Center for MND Research (PhD Studentship)
National Institutes of Health (NINDS 043205)
Article History
Received: 15 January 2020
Accepted: 26 August 2020
First Online: 16 September 2020
Competing interests
: JDC has received research support from BioMarin Pharmaceutical Inc. in addition to Abeona Therapeutics Inc., Regenexbio Inc. and CereSpir Inc. TMW is an academic editor for Scientific Reports.